Evidence map›Paper›PMID 39879294›Full record

ArticleScience advances2025

One-dimensional nanosonosensitizer boosted multiple branches of immune responses against MHC-deficient immune-evasive urologic tumor.

Wei Yang, Sichen Di, Zihuan Yang, Jianwei Cao, Qingqiao Fu, Hongze Ren, Hui Cheng, Yujie Xie, Wencong Jia, Xinyue Dai and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wei YangDepartment of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, P. R. China.ORCID 0000-0003-0565-1913
Sichen DiDepartment of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, P. R. China.ORCID 0000-0002-3533-9085
Zihuan YangMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.ORCID 0009-0006-2392-0995
Jianwei CaoDepartment of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, P. R. China.ORCID 0000-0002-6664-7080
Qingqiao FuSchool of Materials Science and Engineering, Shanghai University, Shanghai 200444, P. R. China.
Hongze RenMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.ORCID 0000-0002-7067-7813
Hui ChengMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.
Yujie XieMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.ORCID 0000-0002-6024-7019
Wencong JiaMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.
Xinyue DaiMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.ORCID 0000-0001-8684-2118
Meihua YuMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.ORCID 0000-0003-3696-7267
Yu ChenMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.ORCID 0000-0002-8206-3325
Xingang CuiDepartment of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, P. R. China.ORCID 0000-0002-0920-9439

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer immunotherapies rely on CD8

Indexed as

Immune EvasionImmunityMajor Histocompatibility ComplexNanoparticlesUrologic NeoplasmsAnimalsAntigen-Presenting CellsBismuthCell DeathCell DifferentiationDendritic CellsDown-RegulationFemaleHumansImmune ToleranceImmunity, InnateBismuthbismuth vanadium tetraoxideVanadates

Identifiers

PMID39879294
PMCPMC11777198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.